Literature DB >> 11839187

Metabolic pathway analysis in trypanosomes and malaria parasites.

Alan H Fairlamb1.   

Abstract

Identification of novel drug targets is required for the development of new classes of drugs to overcome drug resistance and replace less efficacious treatments. In theory, knowledge of the entire genome of a pathogen identifies every potential drug target in any given microbe. In practice, the sheer complexity and the inadequate or inaccurate annotation of genomic information makes target identification and selection somewhat more difficult. Analysis of metabolic pathways provides a useful conceptual framework for the identification of potential drug targets and also for improving our understanding of microbial responses to nutritional, chemical and other environmental stresses. A number of metabolic databases are available as tools for such analyses. The strengths and weaknesses of this approach are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839187      PMCID: PMC1692913          DOI: 10.1098/rstb.2001.1040

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  29 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The EcoCyc and MetaCyc databases.

Authors:  P D Karp; M Riley; M Saier; I T Paulsen; S M Paley; A Pellegrini-Toole
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 3.  Origin, targeting, and function of the apicomplexan plastid.

Authors:  D S Roos; M J Crawford; R G Donald; J C Kissinger; L J Klimczak; B Striepen
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

4.  Integrated pathway-genome databases and their role in drug discovery.

Authors:  P D Karp; M Krummenacker; S Paley; J Wagg
Journal:  Trends Biotechnol       Date:  1999-07       Impact factor: 19.536

5.  Global properties of the metabolic map of Escherichia coli.

Authors:  C A Ouzounis; P D Karp
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

6.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

7.  Guilt-by-association goes global.

Authors:  S Oliver
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

8.  Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.

Authors:  C S Bond; Y Zhang; M Berriman; M L Cunningham; A H Fairlamb; W N Hunter
Journal:  Structure       Date:  1999-01-15       Impact factor: 5.006

Review 9.  Glutathione and trypanothione in parasitic hydroperoxide metabolism.

Authors:  L Flohé; H J Hecht; P Steinert
Journal:  Free Radic Biol Med       Date:  1999-11       Impact factor: 7.376

10.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

Authors:  H Jomaa; J Wiesner; S Sanderbrand; B Altincicek; C Weidemeyer; M Hintz; I Türbachova; M Eberl; J Zeidler; H K Lichtenthaler; D Soldati; E Beck
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

View more
  11 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  The Schistosoma mansoni transcriptome: an update.

Authors:  Guilherme Oliveira
Journal:  Exp Parasitol       Date:  2007-06-12       Impact factor: 2.011

3.  Target repurposing for neglected diseases.

Authors:  Michael P Pollastri; Robert K Campbell
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

Review 4.  Proteomics of the human malaria parasite Plasmodium falciparum.

Authors:  Paul F G Sims; John E Hyde
Journal:  Expert Rev Proteomics       Date:  2006-02       Impact factor: 3.940

5.  Discovery of Novel Pyruvate Kinase Inhibitors Against Leishmania major Among FDA Approved Drugs Through System Biology and Molecular Docking Approach.

Authors:  Nasrin Amiri-Dashatan; Mostafa Rezaei-Tavirani; Mohammad Mehdi Ranjbar; Mehdi Koushki; Seyed Dawood Mousavi Nasab; Nayebali Ahmadi
Journal:  Turk J Pharm Sci       Date:  2021-12-31

6.  Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.

Authors:  Silvane M F Murta; Tim J Vickers; David A Scott; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2009-01-16       Impact factor: 3.501

Review 7.  Methylglyoxal metabolism in trypanosomes and leishmania.

Authors:  Susan Wyllie; Alan H Fairlamb
Journal:  Semin Cell Dev Biol       Date:  2011-02-15       Impact factor: 7.727

8.  Trypanosoma cruzi Coexpressing Ornithine Decarboxylase and Green Fluorescence Proteins as a Tool to Study the Role of Polyamines in Chagas Disease Pathology.

Authors:  Jeremías José Barclay; Luciano Gastón Morosi; María Cristina Vanrell; Edith Corina Trejo; Patricia Silvia Romano; Carolina Carrillo
Journal:  Enzyme Res       Date:  2011-06-01

9.  A comparative study of methylglyoxal metabolism in trypanosomatids.

Authors:  Neil Greig; Susan Wyllie; Stephen Patterson; Alan H Fairlamb
Journal:  FEBS J       Date:  2008-12-03       Impact factor: 5.542

Review 10.  Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.

Authors:  Stephen Patterson; Susan Wyllie
Journal:  Trends Parasitol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.